DNDi is seeking expressions of interest from qualified organizations to support data management, biostatistics, and interactive response technology services for a global Phase III clinical trial in dengue. Expressions of interest must be submitted no later than 8 June 2026. A request for proposal (RFP) will be issued to shortlisted organizations following the expression of interest phase.
